| 摘要 |
<p>Compounds of Formula (IA), IB), IC), and (ID) wherein R<1>, R<2>, R<3>, R<4>, R<5>, and R<6> are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.</p> |
| 申请人 |
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.;BEKKALI, YOUNES;BETAGERI, RAJASHEHAR;EMMANUEL, MICHAEL, J.;HAMMACH, ABDELHAKIM;HARCKEN, HANKE, JUSTUS, JOACHIM;KIRRANE, THOMAS, MARTIN;KUZMICH, DANIEL;LEE, THOMAS, WAI-HO;LIU, PINGRONG;PATEL, USHA, R.;RAZAVI, HOSSEIN;RIETHER, DORIS;TAKAHASHI, HIDENORI;THOMSON, DAVID, S.;WANG, JI;ZINDELL, RENEE;PROUDFOOT, JOHN, ROBERT |
发明人 |
BEKKALI, YOUNES;BETAGERI, RAJASHEHAR;EMMANUEL, MICHAEL, J.;HAMMACH, ABDELHAKIM;HARCKEN, HANKE, JUSTUS, JOACHIM;KIRRANE, THOMAS, MARTIN;KUZMICH, DANIEL;LEE, THOMAS, WAI-HO;LIU, PINGRONG;PATEL, USHA, R.;RAZAVI, HOSSEIN;RIETHER, DORIS;TAKAHASHI, HIDENORI;THOMSON, DAVID, S.;WANG, JI;ZINDELL, RENEE;PROUDFOOT, JOHN, ROBERT |
